Systematic optimization improves catalytic activity and thermostability in α-1,3-fucosyltransferase, suggesting enhanced industrial applicability.
α-1,3-Fucosyltransferase (α-1,3-FucT), the rate-limiting enzyme in the biosynthesis of the human milk oligosaccharide 3-fucosyllactose (3-FL), suffers from limited industrial applicability due to its low catalytic activity and poor thermostability. Herein, we systematically optimized the catalytic performance and thermostability of M32-H10 using computer-aided design coupled with a greedy combinatorial strategy. Four computational tools identified 107 potential mutation sites, and subsequent library screening yielded six beneficial single mutants (S98R, K132I, E134M, D147P, N199F and K301P), exhibiting 28%-84% higher specific activity and improved thermostability (ΔTm increased by 0.22 ∼ 4.87 °C). A stepwise combinatorial approach further generated a quadruple mutant (K132I-E134M-N199F-K301P), which demonstrated synergistic effects: a 116% increase in enzymatic activity over the wild-type, an extended half-life (8.05 h at 40 °C), and robust catalytic efficiency across a broad pH range (5.0 ∼ 8.5). Structural analysis revealed that the mutations optimized substrate binding and conformational stability by remodeling the hydrophobic cluster (I132-M134-F199-P301), strengthening the hydrogen-bond network, and fine-tuning the local rigidity-flexibility balance. This study provides an efficient strategy for enzyme rational design and highlights the critical role of combinatorial mutations in industrial enzyme engineering.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: